ClinConnect ClinConnect Logo
Search / Trial NCT06878235

Validation of the French Version of the Primary Lateral Sclerosis Functioning Rating Scale (PLSFRS)

Launched by UNIVERSITY HOSPITAL, TOURS · Mar 10, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Scale

ClinConnect Summary

This is a prospective study conducted in 8 French ALS centers which will enroll 80 patients with PLS. All these patients will undergo an evaluation of their functional status from the ALSFRS-r and PLSFRS scales. All patients will be evaluated at 3 time points (T0,M6 at the outpatient clinic) and at M3 remotely. The aim of the study will be to validate a trans-cultural and psychometric version of the PLSFRS available for the French PLS population.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with primary lateral sclerosis (PLS)
  • Age over 18 years
  • Informed consent signed
  • Patients cared in a French ALS centre
  • Exclusion Criteria:
  • patients with no oral and written command of the French language
  • Patients unable to answer a questionnaire
  • Opposition to data processing

Trial Officials

Philippe CORCIA, PR

Principal Investigator

University Hospital, Tours

About University Hospital, Tours

The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.

Locations

Lille, , France

Tours, , France

Brest, , France

Clermont Ferrand, , France

Limoges, , France

Lyon, , France

Nice, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported